Literature DB >> 6626919

Prevention of postoperative renal failure in patients with obstructive jaundice--the role of bile salts.

C J Cahill.   

Abstract

Preoperative administration of the simple bile salt sodium deoxycholate has been shown in this study to prevent postoperative endotoxaemia and renal failure in patients with obstructive jaundice. Fifty-four per cent of jaundiced patients not given the salt were found to have systemic endotoxaemia, associated with renal impairment in two-thirds of the cases. No patient given sodium deoxycholate 500 mg 8 hourly for 48 hours before operation had portal or systemic endotoxaemia, and none had evidence of renal impairment (P less than 0 X 02, X2 with Yates' correction). The incidence of endotoxaemia in untreated jaundiced patients was very significantly greater than in non-jaundiced patients undergoing elective upper abdominal surgery (P less than 0 X 005), but this difference is abolished by the prophylactic administration of the oral bile salt. The mechanism of action of bile salts in preventing endotoxin absorption from the small bowel has been investigated, and the lack of any significant alteration in the small bowel microbial flora in obstructive jaundice suggests that a direct effect on the endotoxin molecule is involved. Nearly 20 per cent of patients with obstructive jaundice still develop postoperative renal insufficiency, but preoperative prophylactic use of sodium deoxycholate should reduce this very significantly.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626919     DOI: 10.1002/bjs.1800701008

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  25 in total

Review 1.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

2.  Protective effect of the intravenous administration of ursodeoxycholic acid against endotoxemia in rats with obstructive jaundice.

Authors:  Y Hori; H Ohyanagi
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 3.  Intestinal endotoxins and macrophages as mediators of liver injury.

Authors:  J P Nolan; D S Camara
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

4.  Palliation for carcinoma of head of pancreas.

Authors:  C S Ubhi; J Doran
Journal:  Ann R Coll Surg Engl       Date:  1986-05       Impact factor: 1.891

5.  Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.

Authors:  J W Greve; D J Gouma; P A von Leeuwen; W A Buurman
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

6.  The effect of oral sodium taurocholate on endotoxemia and intestinal anastomotic wound healing in rats with obstructive jaundice.

Authors:  M Sayan; A Alponat; N Yavuz; E Altinkaya; S Göksel; M Sariyar
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

7.  Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice.

Authors:  F K Welsh; C W Ramsden; K MacLennan; M B Sheridan; G R Barclay; P J Guillou; J V Reynolds
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

8.  Altered serum transforming growth factor-beta1 and monocyte chemoattractant protein-1 levels in obstructive jaundice.

Authors:  Shyr-Ming Sheen-Chen; Hock-Liew Eng; Kuo-Sheng Hung
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

9.  Effect of biliary drainage on inducible nitric oxide synthase, CD14 and TGR5 expression in obstructive jaundice rats.

Authors:  Zi-Kai Wang; Jian-Guo Xiao; Xue-Fei Huang; Yi-Chun Gong; Wen Li
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Obstructive jaundice alters proliferating cell nuclear antigen expression in rat small intestine.

Authors:  Shyr-Ming Sheen-Chen; Hsin-Tsung Ho; Wei-Jen Chen; Hock-Liew Eng
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.